Amundi Asset Management US’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$16.5M Buy
179,491
+38,188
+27% +$3.52M 0.01% 716
2020
Q4
$10.3M Buy
141,303
+69,547
+97% +$5.09M 0.01% 792
2020
Q3
$5.57M Buy
71,756
+57,156
+391% +$4.44M 0.01% 863
2020
Q2
$811K Hold
14,600
﹤0.01% 1190
2020
Q1
$432K Sell
14,600
-4,800
-25% -$142K ﹤0.01% 1213
2019
Q4
$702K Hold
19,400
﹤0.01% 1277
2019
Q3
$528K Buy
19,400
+13,300
+218% +$362K ﹤0.01% 1300
2019
Q2
$147K Hold
6,100
﹤0.01% 1498
2019
Q1
$161K Sell
6,100
-18,100
-75% -$478K ﹤0.01% 1449
2018
Q4
$473 Sell
24,200
-23,800
-50% -$465 ﹤0.01% 1257
2018
Q3
$940K Sell
48,000
-394,300
-89% -$7.72M ﹤0.01% 1235
2018
Q2
$7.32M Buy
+442,300
New +$7.32M 0.01% 813